UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review

Cancer causes & control, 2020-09, Vol.31 (9), p.801-814

2020

Volltextzugriff (PDF)

The Feminization of HIV: A Retrospective Demographic and Health Surveys Study of Women’s Empowerment Factors in Southern Africa

International journal of health, wellness & society, 2021, Vol.11 (2), p.19-40

2021

Volltextzugriff (PDF)

Cancer treatment and outcomes in patients of color or ethnic minority (PCEM): Oncologist perceptions of racial anxiety and/or implicit bias (RA/IB)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.104-104

2021

Volltextzugriff (PDF)

Interaction with patients of color or ethnic minority (PCEM): Oncologist perceptions of racial anxiety and/or implicit bias (RA/IB)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.141-141

2021

Volltextzugriff (PDF)

HSR23-094: Uterine Cancer (UC) on the Rise in the United States (US): One of the Largest Racial Disparities in Oncology

Journal of the National Comprehensive Cancer Network, 2023-03, Vol.21 (3.5), p.HSR23-094

2023

Volltextzugriff (PDF)

Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.12-12

2020

Volltextzugriff (PDF)

Oncologist perceptions of health inequity

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18656-e18656

2023

Volltextzugriff (PDF)

Abstract C099: Assessment of black/white differences in all-cause mortality among patients with triple-negative breast cancer

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.C099-C099

2020

Volltextzugriff (PDF)

Comparison of diversity across real-world evidence, randomized clinical trial, and Surveillance, Epidemiology, and End Results (SEER) data in patients with metastatic breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18670-e18670

2023

Volltextzugriff (PDF)

CAR T Therapy Referral for Diffuse Large B Cell Lymphoma (DLBCL) By U.S. Community Hematology/Oncology (cH/O) Practices: Perceptions and Patterns

Blood, 2021-11, Vol.138 (Supplement 1), p.4977-4977

2021

Volltextzugriff (PDF)

BPI23-009: Oncologists’ Perceptions of a Novel Superoxide Dismutase Mimetic (Avasopasem Manganese) for Treating Severe Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Journal of the National Comprehensive Cancer Network, 2023-03, Vol.21 (3.5), p.BPI23-009

2023

Volltextzugriff (PDF)

Impact of an augmented intelligence-based tool upon the timeliness of referrals to palliative care and hospice in patients with advanced cancer in the real-world setting

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12127-12127

2022

Volltextzugriff (PDF)

Real-World Eculizumab Effectiveness on US Patient Outcomes in Myasthenia Gravis (ELEVATE): a Retrospective Chart Review (S41.010)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

HSR24-172: Comparing Apples to Apples in Uterine Cancer: Racial Disparity and Propensity Score Matching

Journal of the National Comprehensive Cancer Network, 2024-04, Vol.22 (2.5)

2024

Volltextzugriff (PDF)

US physician perceptions of treatment decision making for advanced renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.311-311

2022

Volltextzugriff (PDF)

Abstract B076: Did the Affordable Care Act improve insurance coverage and stage at diagnosis among nonelderly underserved breast cancer patients?

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B076-B076

2020

Volltextzugriff (PDF)

Real-World Use of Eculizumab in Generalized Myasthenia Gravis in the United States: Results From a Pilot Retrospective Chart-Review Study (1917)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Racial differences in treatment patterns and outcomes of first-line (1L) therapies for advanced renal cell carcinoma (aRCC) in the real-world (RW) setting

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4548-4548

2022

Volltextzugriff (PDF)

Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and Outcomes

Journal of the National Comprehensive Cancer Network, 2024-03, Vol.22 (2), p.82-90

2024

Volltextzugriff (PDF)

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

Blood, 2021-11, Vol.138 (Supplement 1), p.1980-1980

2021

Volltextzugriff (PDF)

Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure

Blood, 2021-11, Vol.138 (Supplement 1), p.3059-3059

2021

Volltextzugriff (PDF)

Characterizing patients with breast cancer who seek second opinions at an academic cancer center

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19229-e19229

2020

Volltextzugriff (PDF)

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

The oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.414-424

2023

Volltextzugriff (PDF)

Racial disparity in uterine cancer treatment and survival: A matter of Black women’s lives

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6550-6550

2021

Volltextzugriff (PDF)

The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community Oncologists

JCO oncology practice, 2022-07, Vol.18 (7), p.OP2100743-e1090

2022

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review

The Feminization of HIV: A Retrospective Demographic and Health Surveys Study of Women’s Empowerment Factors in Southern Africa

Cancer treatment and outcomes in patients of color or ethnic minority (PCEM): Oncologist perceptions of racial anxiety and/or implicit bias (RA/IB)

Interaction with patients of color or ethnic minority (PCEM): Oncologist perceptions of racial anxiety and/or implicit bias (RA/IB)

HSR23-094: Uterine Cancer (UC) on the Rise in the United States (US): One of the Largest Racial Disparities in Oncology

Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

Oncologist perceptions of health inequity

Abstract C099: Assessment of black/white differences in all-cause mortality among patients with triple-negative breast cancer

Comparison of diversity across real-world evidence, randomized clinical trial, and Surveillance, Epidemiology, and End Results (SEER) data in patients with metastatic breast cancer

CAR T Therapy Referral for Diffuse Large B Cell Lymphoma (DLBCL) By U.S. Community Hematology/Oncology (cH/O) Practices: Perceptions and Patterns

BPI23-009: Oncologists’ Perceptions of a Novel Superoxide Dismutase Mimetic (Avasopasem Manganese) for Treating Severe Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Impact of an augmented intelligence-based tool upon the timeliness of referrals to palliative care and hospice in patients with advanced cancer in the real-world setting

Real-World Eculizumab Effectiveness on US Patient Outcomes in Myasthenia Gravis (ELEVATE): a Retrospective Chart Review (S41.010)

HSR24-172: Comparing Apples to Apples in Uterine Cancer: Racial Disparity and Propensity Score Matching

US physician perceptions of treatment decision making for advanced renal cell carcinoma

Abstract B076: Did the Affordable Care Act improve insurance coverage and stage at diagnosis among nonelderly underserved breast cancer patients?

Real-World Use of Eculizumab in Generalized Myasthenia Gravis in the United States: Results From a Pilot Retrospective Chart-Review Study (1917)

Racial differences in treatment patterns and outcomes of first-line (1L) therapies for advanced renal cell carcinoma (aRCC) in the real-world (RW) setting

Oncologist Perceptions of Racial Disparity, Racial Anxiety, and Unconscious Bias in Clinical Interactions, Treatment, and Outcomes

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure

Characterizing patients with breast cancer who seek second opinions at an academic cancer center

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

Racial disparity in uterine cancer treatment and survival: A matter of Black women’s lives

The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community Oncologists

Suchergebnisse filtern